Back to Baillie Gifford & Co. Baillie Gifford & Co.

DXCMDXCM

Showing 8 of 30 quarters

Position history for Baillie Gifford & Co.Baillie Gifford & Co.'s holdings in DexCom, Inc.

Yes. Baillie Gifford holds 14,801,590 shares of DXCM (DexCom), worth $996.9M, as of its Q2 2026 13F filing. It reduced the position by 797,935 shares (-5.1%) from Q1 2026. Baillie Gifford has held DXCM in every 13F on record since Q1 2019, 30 quarterly filings. DXCM is 0.9% of Baillie Gifford's reported 13F portfolio.

Current Value

$996.9M

Current Shares

14.8M

Total Value Change

-$9.9M

Total Shares Change

-216,076

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
14.8M
-5.1%
$996.9M0.9%$67.35
0
2026-Q1
Increased
15.6M
+0.3%
$979.7M1.0%$62.80
50
2025-Q4
Decreased
15.6M
-2.1%
$1B0.9%$66.37
0
2025-Q3
Decreased
15.9M
-4.9%
$1.1B0.8%$67.29
0
2025-Q2
Increased
16.7M
+17.8%
$1.5B1.1%$87.29
59
2025-Q1
Decreased
14.2M
-3.0%
$968.3M0.8%$68.29
0
2024-Q4
Decreased
14.6M
-2.7%
$1.1B0.9%$77.77
0
2024-Q3
Decreased
15M
-2.0%
$1B0.8%$67.04
0

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used